Lepu Biopharma Co., Ltd. (2157.HK)
HKD 3.31
(0.91%)
HKD 3.31
(0.91%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 197.07 Million CNY | 1352.61% |
| 2022 | 13.56 Million CNY | 0.0% |
| 2021 | - CNY | 0.0% |
| 2020 | - CNY | 0.0% |
| 2019 | - CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 60.82 Million HKD | 3368.1% |
| 2024 Q2 | 60.3 Million HKD | -0.15% |
| 2023 Q3 | 26.42 Million HKD | -75.73% |
| 2023 FY | 197.07 Million CNY | 1352.61% |
| 2023 Q4 | -1.89 Million HKD | -107.18% |
| 2023 Q2 | 108.86 Million HKD | 28.88% |
| 2023 Q1 | 84.46 Million HKD | 305.89% |
| 2022 FY | 13.56 Million CNY | 0.0% |
| 2022 Q2 | -54.71 Million HKD | 0.0% |
| 2022 Q4 | -41.02 Million HKD | 0.0% |
| 2021 FY | - CNY | 0.0% |
| 2021 Q2 | -57 Million HKD | 0.0% |
| 2020 FY | - CNY | 0.0% |
| 2019 FY | - CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Uni-Bio Science Group Limited | 392.81 Million HKD | 49.83% |
| CK Life Sciences Int'l., (Holdings) Inc. | 947.7 Million HKD | 79.205% |